Table 2.
Models for prediction of presence and severity of late gadolinium enhancement (LGE)
| Slice | Factor | Odds ratio and 95% CI | p value | |
|---|---|---|---|---|
| Presence/absence of LGE | ||||
| Base (n = 105) | Native T1 | 2.1 [1.2, 3.8] | 0.012 | |
| εcc | 2.6 [1.1, 6.1] | 0.034 | ||
| εls | 2.3 [1.1, 4.8] | 0.032 | ||
| Mid (n = 133) | Native T1 | 1.2 [0.8, 1.7] | 0.42 | |
| εcc | 2.4 [1.2, 4.7] | 0.009 | ||
| εls | 2.3 [1.4, 3.7] | 0.001 | ||
| Apex (n = 106) | Native T1 | 1.4 [0.7, 2.8] | 0.30 | |
| εcc | 1.9 [0.9, 4.1] | 0.12 | ||
| εls | 1.0 [0.4, 2.6] | 0.93 | ||
| Global (n = 121) | Native T1 | 1.5 [0.8, 2.6] | 0.17 | |
| εcc | 2.3 [1.0, 5.1] | 0.049 | ||
| εls | 2.6 [1.1, 6.0] | 0.029 | ||
| Global severity score | ||||
| Base (n = 104) | Native T1 | 2.2 [ 1.1, 4.6] | 0.026 | |
| εcc | 3.3 [1.2, 3.3] | < 0.001 | ||
| εls | 2.0 [1.9, 5.7] | 0.006 | ||
| Mid (n = 132) | Native T1 | 1.3 [ 1.0, 1.9] | 0.085 | |
| εcc | 2.8 [1.7, 4.6] | < 0.001 | ||
| εls | 2.1 [1.5, 3.1] | < 0.001 | ||
| Apex (n = 105) | Native T1 | 0.9 [ 0.6, 1.5] | 0.25 | |
| εcc | 1.8 [0.9, 3.4] | 0.077 | ||
| εls | 1.8 [0.9, 3.2] | 0.085 | ||
| Global (n = 120) | Native T1 | 1.8 [ 1.1, 3.1] | 0.025 | |
| εcc | 2.6 [1.4, 4.8] | 0.002 | ||
| εls | 2.6 [1.4, 4.7] | 0.002 | ||
| FWHM | ||||
| Base (n = 103) | Native T1 | 1.4 [0.9, 2.2] | 0.19 | |
| εcc | 2.0 [1.1, 3.5] | 0.017 | ||
| εls | 1.5 [1.0, 2.2] | 0.038 | ||
| Mid (n = 114) | Native T1 | 1.1 [0.8, 1.6] | 0.58 | |
| εcc | 2.2 [1.3, 3.5] | 0.002 | ||
| εls | 1.7 [1.1, 2.5] | 0.014 | ||
| Apex (n = 103) | Native T1 | 1.0 [0.6, 1.5] | 0.85 | |
| εcc | 1.3 [0.8, 2.3] | 0.26 | ||
| εls | 0.9 [0.5, 1.6] | 0.70 | ||
| Global (n = 119) | Native T1 | 1.3 [0.8, 2.2] | 0.28 | |
| εcc | 1.4 [0.9, 2.2] | 0.19 | ||
| εls | 2.0 [1.2, 3.5] | 0.01 | ||
Bold italic values are significant for p ≤ 0.05
FWHM full width half maximum